Search

Your search keyword '"Humira (Medication) -- Prices and rates"' showing total 3 results
Start Over Descriptor "Humira (Medication) -- Prices and rates" Publication Year Range Last 3 years
3 results on '"Humira (Medication) -- Prices and rates"'

1. The Opaque Industry Secretly Inflating Prices for Prescription Drugs

Author

Robbins, Rebecca and Abelson, Reed

Subjects
CVS Health Corp. -- Prices and rates, CIGNA Corp. -- Prices and rates, Express Scripts Inc. -- Prices and rates, UnitedHealth Group Inc. -- Prices and rates, Health maintenance organizations -- Prices and rates, Employers, Drugs -- Prescribing, Drugstores -- Prices and rates, Americans, Company pricing policy, General interest, Humira (Medication) -- Prices and rates
Abstract

Byline: Rebecca Robbins and Reed Abelson Americans are paying too much for prescription drugs. It is a common, longstanding complaint. And the culprits seem obvious: Drug companies. Insurers. A dysfunctional [...]

Published
2024

2. The Opaque Industry Secretly Inflating Prices for Prescription Drugs

Author

Robbins, Rebecca and Abelson, Reed

Subjects
CVS Health Corp. -- Officials and employees, CIGNA Corp. -- Officials and employees, Express Scripts Inc. -- Officials and employees, UnitedHealth Group Inc. -- Officials and employees, Health maintenance organizations -- Prices and rates -- Officials and employees, Employers, Drugs -- Prescribing, Drugstores -- Officials and employees -- Prices and rates, Americans, Company pricing policy, News, opinion and commentary, Humira (Medication) -- Prices and rates
Abstract

Americans are paying too much for prescription drugs. It is a common, longstanding complaint. And the culprits seem obvious: Drug companies. Insurers. A dysfunctional federal government. But there is another [...]

Published
2024

3. AbbVie will feel the squeeze under new drug pricing law; Its blockbuster Humira is on a new list of 27 drugs that saw prices rise faster than inflation in 2022 -- triggering penalties and rebates under rules passed last year

Subjects
United States. Department of Health and Human Services -- Laws, regulations and rules, Social service -- Prices and rates, Pricing -- Laws, regulations and rules, Antiarthritic agents -- Prices and rates, Inflation (Finance) -- Laws, regulations and rules, Pharmaceutical industry -- Prices and rates -- Laws, regulations and rules, Government regulation, Product price, Company pricing policy, Business, Business, regional, Humira (Medication) -- Prices and rates
Abstract

Byline: Katherine Davis Humira, the rheumatoid arthritis medication made by pharmaceutical giant AbbVie, is among the first group of drugs that will face a penalty under a new law prohibiting [...]

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results